One under-$10 stock that's trending very close to trigger a near-term breakout trade is
Antares Pharma (
ATRS), which is a specialty pharmaceutical company developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. This stock has been moving higher in 2013, with shares up by 12.4%.
If you take a look at the chart for Antares Pharma, you'll notice that this stock is bouncing sharply to the upside today right off its 50-day moving average of $3.53 a share. This move has started to push shares of ATRS above a key downtrend line that has been acting as resistance for the stock since February. Shares of ATRS are also starting to break out above some near-term overhead resistance at $3.63 to $3.71 a share. That move is quickly pushing the stock within range of triggering another major breakout trade.
>>4 Stocks Spiking on Big Volume
Traders should now look for long-biased trades in ATRS if it manages to break out above some near-term overhead resistance levels at $3.71 to $3.80 a share and then once it clears more resistance at its 200-day at $3.94 and at $4 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 885,916 shares. If that breakout triggers soon, then ATRS will set up to re-test or possibly take out its next major overhead resistance levels at $4.38 to $4.73 a share. Any high-volume move above $4.73 will then put $5.25 to $5.50 into range for shares of ATRS.
Traders can look to buy ATRS off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day at $3.53 a share. One can also buy off strength once ATRS off strength once it takes out those breakout levels with volume and then simply use a stop just below $3.63 a share.
This stock has a decent amount of bears involved in the name, since the current short interest as a percentage of the float for ATRS is pretty high at 9.8%. We could easily see this stock short-squeeze rapidly higher from current levels if the price action remains bullish.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts